Efficacy of Different Treatments for the Intensive Care Unit Acquired Weakness
NCT ID: NCT04613908
Last Updated: 2020-11-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
18 participants
INTERVENTIONAL
2015-08-01
2016-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Ethical considerations: The research protocol was presented and approved by both the Ethics Committee and the Teaching and Research Committee of our institution. The informed consent of each subject included in the study was obtained.
Sample size and study power: a sample size was defined in 18 subjects (6 subjects per intervention group). The estimation of the sample was calculated for a one-way ANOVA where a minimum difference of 2 sessions was established between the treatments, assuming a standard deviation of 1.8 sessions, an alpha error of 5% and a power of 80%.
Statistical methods: the numerical variables will be presented as mean and standard deviation or median and interquartile range according to the presented distribution. The categorical variables will be presented by frequency and percentage.
For the comparison of continuous variables, Student's t test for independent samples or the Mann-Whitney U test will be used according to the presented distribution and for the categorical variables the Chi² test or the Fisher exact test will be used according to the conformation of the crossed table. The Shapiro-Wilk test will be used to evaluate whether the distribution presented by the numerical variables fits a normal distribution. Equality of variances was assessed by the Levene´s test.
The comparison of the time to reach an smuscle strength scale of the MRC ≥ 48 between the groups with different interventions will be used the one-way ANOVA test or the Kruskal-Wallis test as appropriate. For post hoc analysis, the pairs-comparison test of Games-Hollew or Dunn's-Bonferroni will be used for ANOVA or Kruskal-Wallis, respectively, when they reach statistical significance.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
Group 2 (GR-NMES) received neuro muscular electro stimulation sessions in addition to the standard treatment.
Group 3 (GR-EM) received an early mobilization protocol as intervention.
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
standard care or usual rehabilitation
It will consist of the usual treatment performed by the intensive care physiotherapist, it will be applied every day that the study lasts.
standard care or usual rehabilitation
routine, non-protocolized rehabilitation treatment performed by the physiotherapist assigned to intensive care
neuro muscular electro stimulation
They received 5 sessions per week (except weekends) of neuromuscular electrostimulation of 30 minutes duration. Also, every day that the study is carried out in the morning and in the afternoon, the subjects will receive the usual treatment performed by the intensive care physiotherapist.
neuro muscular electro stimulation
We used a commercial equipment of electro stimulation with a pulse width of 300 micro seconds, a frequency of 50 Hz, with symmetrical balanced biphasic rectangular wave and with an intensity of up to 80 milliampere.
early mobilization protocol
Throughout the duration of the study, an early mobilization protocol will be applied to apply a specific treatment based on different levels of treatment for each subject of the group; It differs from the usual procedure in protocolized progression according to the objectives reached by the patient, unlike the usual treatment, where the progression is in accordance with the clinical criteria of the treatment professional.
Early Mobilization protocol
The protocol consisted in applying a specific treatment based on different levels of treatment to each subject. Admission to them was carried out according to the maximum capacity of each subject, the conditions of each level being the following:
* Level 1: MRC (shoulder) \<3 + MRC \<3 (hip).
* Level 2: MRC (shoulder) ≥ 3 + MRC (hip) \<3.
* Level 3: MRC (shoulder) ≥ 3 + MRC (hip) ≥ 3 + sitting on the edge of the bed without assistance (minimum 15 minutes).
* Level 4: Standing without assistance and walking with or without assistance.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
neuro muscular electro stimulation
We used a commercial equipment of electro stimulation with a pulse width of 300 micro seconds, a frequency of 50 Hz, with symmetrical balanced biphasic rectangular wave and with an intensity of up to 80 milliampere.
Early Mobilization protocol
The protocol consisted in applying a specific treatment based on different levels of treatment to each subject. Admission to them was carried out according to the maximum capacity of each subject, the conditions of each level being the following:
* Level 1: MRC (shoulder) \<3 + MRC \<3 (hip).
* Level 2: MRC (shoulder) ≥ 3 + MRC (hip) \<3.
* Level 3: MRC (shoulder) ≥ 3 + MRC (hip) ≥ 3 + sitting on the edge of the bed without assistance (minimum 15 minutes).
* Level 4: Standing without assistance and walking with or without assistance.
standard care or usual rehabilitation
routine, non-protocolized rehabilitation treatment performed by the physiotherapist assigned to intensive care
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* admitted to the ICU who have received invasive mechanical ventilation for a period longer than 24 hours
* clinical diagnosis of ICUAW (MRC-mss \<48 measured over two consecutive days).
Exclusion Criteria
* presence of edema that prevents the realization of NMES at the time of diagnosis of ICUAW (assessed by the absence of visible contraction
* pregnant women
* subjects with pacemakers
* subjects with injury of the central and / or peripheral nervous system (with motor sequelae)
* previous neuromuscular disease
* limitation of the movement of any extremity due to orthopedic or traumatological causes
* presence of a previous cognitive disorder that impedes the understanding of rehabilitation interventions
* a value of the index of Barthel less than 35 points at admission
* subjets who refused to give informed consent.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital Nacional Profesor Alejandro Posadas
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ladislao Diaz Ballve
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ladislao P Diaz Ballve
Role: PRINCIPAL_INVESTIGATOR
Hospital Nacional Posadas
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
02-2018
Identifier Type: -
Identifier Source: org_study_id